Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02362997 · OUTCOME

Overall Survival After ASCT by PET Status

Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL · Source last updated 2026-05-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
survival probability
Interval / dispersion
90% Confidence Interval
Time frame
18 months

What was measured

Survival probability of patients alive 18 months from ASCT stratified by PET status before transplantation, time-to-event. Patients categorized by complete metabolic response (complete response by PET scan, assessed using the Lugano 2014 criteria), partial response (assessed using Lugano 2014 criteria) prior to transplantation.

Groups in this outcome

Diffuse Large B Cell Lymphoma, PET-CR

Diffuse Large B Cell Lymphoma patients who were PET-CR before transplantation

Diffuse Large B Cell Lymphoma, PET-NCR

Diffuse Large B Cell Lymphoma patients who were not PET-CR before transplantation

Classical Hodgkin Lymphoma - PET-CR

Classical Hodgkin Lymphoma patients who were PET-CR before transplantation

Classical Hodgkin Lymphoma - PET-NCR

Classical Hodgkin Lymphoma patients who were not PET-CR before transplantation

Peripheral T Cell - PET-CR

Peripheral T Cell patients who were PET-CR before transplantation

Peripheral T Cell - PET-NCR

Peripheral T Cell patients who were not PET-CR before transplantation

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Diffuse Large B Cell Lymphoma, PET-CR20
Diffuse Large B Cell Lymphoma, PET-NCR11
Classical Hodgkin Lymphoma - PET-CR23
Classical Hodgkin Lymphoma - PET-NCR7
Peripheral T Cell - PET-CR19
Peripheral T Cell - PET-NCR2

Reported measurements

Source class 1
Values in survival probability · Interval/dispersion: 90% Confidence Interval
GroupValueSpreadLowerUpperComment
Diffuse Large B Cell Lymphoma, PET-CR0.94Not reported0.851.0Not reported
Diffuse Large B Cell Lymphoma, PET-NCR0.91Not reported0.781.0Not reported
Classical Hodgkin Lymphoma - PET-CR1.0Not reported1.01.0Not reported
Classical Hodgkin Lymphoma - PET-NCR1.0Not reported1.01.0Not reported
Peripheral T Cell - PET-CR0.94Not reported0.841.0Not reported
Peripheral T Cell - PET-NCR1.0Not reported1.01.0Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.85
        upper Limit
        1.0
        value
        0.94
      2. group Id
        OG001
        lower Limit
        0.78
        upper Limit
        1.0
        value
        0.91
      3. group Id
        OG002
        lower Limit
        1.0
        upper Limit
        1.0
        value
        1.0
      4. group Id
        OG003
        lower Limit
        1.0
        upper Limit
        1.0
        value
        1.0
      5. group Id
        OG004
        lower Limit
        0.84
        upper Limit
        1.0
        value
        0.94
      6. group Id
        OG005
        lower Limit
        1.0
        upper Limit
        1.0
        value
        1.0
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    2. group Id
      OG001
      value
      11
    3. group Id
      OG002
      value
      23
    4. group Id
      OG003
      value
      7
    5. group Id
      OG004
      value
      19
    6. group Id
      OG005
      value
      2
    units
    Participants
description
Survival probability of patients alive 18 months from ASCT stratified by PET status before transplantation, time-to-event. Patients categorized by complete metabolic response (complete response by PET scan, assessed using the Lugano 2014 criteria), partial response (assessed using Lugano 2014 criteria) prior to transplantation.
dispersion Type
90% Confidence Interval
groups
  1. description
    Diffuse Large B Cell Lymphoma patients who were PET-CR before transplantation
    id
    OG000
    title
    Diffuse Large B Cell Lymphoma, PET-CR
  2. description
    Diffuse Large B Cell Lymphoma patients who were not PET-CR before transplantation
    id
    OG001
    title
    Diffuse Large B Cell Lymphoma, PET-NCR
  3. description
    Classical Hodgkin Lymphoma patients who were PET-CR before transplantation
    id
    OG002
    title
    Classical Hodgkin Lymphoma - PET-CR
  4. description
    Classical Hodgkin Lymphoma patients who were not PET-CR before transplantation
    id
    OG003
    title
    Classical Hodgkin Lymphoma - PET-NCR
  5. description
    Peripheral T Cell patients who were PET-CR before transplantation
    id
    OG004
    title
    Peripheral T Cell - PET-CR
  6. description
    Peripheral T Cell patients who were not PET-CR before transplantation
    id
    OG005
    title
    Peripheral T Cell - PET-NCR
param Type
NUMBER
reporting Status
POSTED
time Frame
18 months
title
Overall Survival After ASCT by PET Status
type
OTHER_PRE_SPECIFIED
unit Of Measure
survival probability

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice